CLINICAL_TRIALS
trial_result
· 2017-05-30
Clinical Trial Update: Long Term Safety of Naldemedine [Phase 3]
Summary
Phase 3 long-term safety results for naldemedine in opioid-induced constipation were reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shionogi | Conditions: Opioid-induced Constipation | Phase 3 | Status: COMPLETED | Results posted: 2017-05-30